Behcet's Disease: Systemic and Ocular Manifestations

被引:26
|
作者
Paovic, Jelena [1 ]
Paovic, Predrag [1 ]
Sredovic, Vojislav [2 ]
机构
[1] Clin Ctr Belgrade, Dept Ophthalmol, Belgrade 11000, Serbia
[2] Ctr Diagnost & Treatment Uveitis, Uvea Ctr, Belgrade 11000, Serbia
关键词
INFLIXIMAB; ASSOCIATION; ETIOLOGY; THERAPY; MANAGEMENT; FEATURES; UVEITIS; HLA-B51; RISK;
D O I
10.1155/2013/247345
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aim. The aim of this study was to evaluate if patients with Behcet's disease who have ocular involvement have a more severe form of this disease as compared to patients with Behcet's disease alone. Methods. A total of 99 patients were included in the study. 76 patients were used as part of the examined group, and 23 patients formed a control group. Results. The following are the results of examined and control groups, respectively: recurrent oral aphthous ulcers 89.5%, 95.7%; genital ulcers 61.8%, 97.0%; articular involvement 72.4%, 65.2%; vasculitis 81.6%, 60.9%; positive pathergy test 25.0%, 47.8%. Higher frequency of genital ulcerations was noted in control group (P = 0.001). More than two major criteria were met in 100% of the cases. HLA B51 was present in 78.9% of the cases in the examined group and 43.5% of the cases in control group; thus there is significant difference between them (P = 0.001). Visual acuity >0.5 occurred in 76% (examined group). Most frequent ocular manifestations in the examined group were retinal periphlebitis 81.6%, periphlebitis and periarteritis 65%, and serofibrinous uveitis 63.2%. Macular edema as a complication was present in 63.2%. The majority of patients (55.3%) were treated with combined therapy consisting of cyclosporine A and systemic corticosteroids. In 38.2% of patients, laser photocoagulation was used on retinal periphery.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Ocular manifestations of Behcet's disease
    Saadouli, D.
    Lahmar, A.
    Ben Mansour, K.
    El Afrit, N.
    Yahyaoui, S.
    El Afrit, M. A.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (02): : 196 - 202
  • [2] Ocular manifestations of Behcet's disease
    Ebenezer, AS
    Moses, PD
    George, R
    [J]. INDIAN PEDIATRICS, 2005, 42 (09) : 942 - 945
  • [3] Ocular manifestations in Behcet's disease
    Desbois, A-C
    Terrada, C.
    Cacoub, P.
    LeHoang, P.
    Saadoun, D.
    Bodaghi, B.
    [J]. REVUE DE MEDECINE INTERNE, 2018, 39 : A31 - A36
  • [4] Ocular manifestations in Behcet's disease
    Desbois, A. -C.
    Terrada, C.
    Cacoub, P.
    Bodaghi, B.
    Saadoun, D.
    [J]. REVUE DE MEDECINE INTERNE, 2018, 39 (09): : 738 - 745
  • [5] Ocular manifestations in Behcet's disease
    Zeghidi, H.
    Saadoun, D.
    Bodaghi, B.
    [J]. REVUE DE MEDECINE INTERNE, 2014, 35 (02): : 97 - 102
  • [6] Ocular manifestations of Behcet's disease
    Saadoun, D.
    Cassoux, N.
    Wechsler, B.
    Boutin, D.
    Terrada, C.
    Lehoang, P.
    Bodaghi, B.
    Cacoub, P.
    [J]. REVUE DE MEDECINE INTERNE, 2010, 31 (08): : 545 - 550
  • [7] Behcet Disease in the United States: Ocular and Systemic Manifestations
    Ucar, Didar
    Dalal, Monica D.
    Fox, Austin
    Tucker, William R.
    Bhatt, Nirali
    Nussenblatt, Robert B.
    Sen, H. Nida
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [8] OCULAR MANIFESTATIONS IN PATIENTS WITH BEHCET'S DISEASE
    Toujani, S.
    Metoui, L.
    Ajili, F.
    Gharsallah, I.
    Ben Abdelhafidh, N.
    Louzir, B.
    Othmani, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 934 - 935
  • [9] Ocular manifestations of Behcet's disease.
    Cassoux, N
    Fardeau, C
    Lehoang, P
    [J]. ANNALES DE MEDECINE INTERNE, 1999, 150 (07): : 529 - 534
  • [10] Ocular manifestations of Behcet's disease in Jordanian patients
    Abu-Ameerh, Mohammed A.
    Mohammed, Sawsan F.
    Mohammad, Mona T.
    Ababneh, Osama H.
    Al-Bdour, Muawyah D.
    [J]. SAUDI JOURNAL OF OPHTHALMOLOGY, 2013, 27 (04) : 247 - 251